iCardiac Technologies
iCardiac | Cardiac and Pulmonary Safety Assessment for Human Drug Trials.
Launch date
Employees
Market cap
-
Enterprise valuation
€15—22m (Dealroom.co estimates Nov 2006.)
Town of Pittsford New York (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Debt | ||
$4.0m | Series A | ||
N/A | N/A | Series B | |
N/A | Seed | ||
N/A | Grant | ||
N/A | N/A | Acquisition | |
Total Funding | €3.6m |
Related Content
Recent News about iCardiac Technologies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.